CTI BIOPHARMA CORP Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Cti Biopharma Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
- Cti Biopharma Corp Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2023 was -$13.4M, a 63.9% increase year-over-year.
- Cti Biopharma Corp Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2023 was -$69.2M, a 41.2% increase year-over-year.
- Cti Biopharma Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$93M, a 5.02% increase from 2021.
- Cti Biopharma Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$97.9M, a 86.7% decline from 2020.
- Cti Biopharma Corp annual Net Income (Loss) Attributable to Parent for 2020 was -$52.5M, a 31.1% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)